TAEST16001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAEST16001, covering 2023-12-27 to 2023-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of TAEST16001 in Soft Tissue Sarcoma [Phase 2]